BMY.USD fundamentals
BRISTOL MYERS SQUIB revenue breakdown overview
BRISTOL MYERS SQUIB revenue for the last year amounted to 48.30 B USD, the most of which — 48.30 B USD — came from its highest performing source at the moment, Innovative Medicines, the year earlier bringing 45.01 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought BRISTOL MYERS SQUIB 34.10 B USD, and the year before that — 31.55 B USD.
By source
2017
2018
2019
2020
2021
2022
2023
2024
0.00
13.00 B
26.00 B
39.00 B
52.00 B
Innovative Medicines
Currency: USD
2017
2018
2019
2020
2021
2022
2023
2024
Innovative Medicines
42.52 B
46.38 B
46.16 B
45.01 B
48.30 B
By country
2017
2018
2019
2020
2021
2022
2023
2024
0.00
13.00 B
26.00 B
39.00 B
52.00 B
United States
International
Global
Europe
Japan
Currency: USD
2017
2018
2019
2020
2021
2022
2023
2024
United States
26.58 B
29.21 B
31.83 B
31.55 B
34.10 B
International
5.46 B
5.63 B
13.50 B
12.75 B
13.20 B
Global
631.00 M
852.00 M
834.00 M
699.00 M
996.00 M
Europe
9.85 B
10.69 B
—
—
—
Japan
—
—
—
—
—